Global Somatostatin Analogue Drug Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Somatostatin Analogue Drug will have significant change from previous year. According to our latest study, the global Somatostatin Analogue Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Somatostatin Analogue Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Somatostatin Analogue Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Somatostatin Analogue Drug market, reaching US$ million by the year 2028. As for the Europe Somatostatin Analogue Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Somatostatin Analogue Drug players cover Camurus AB, Chiasma, Ipsen Group, and Boehringer Ingelheim International GmbH, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Somatostatin Analogue Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Octreotide
Lanreotide
Pasireotide
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Acromegaly
Neuroendocrine Tumor (NET)
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Camurus AB
Chiasma
Ipsen Group
Boehringer Ingelheim International GmbH
Eli Lilly & Co.
F. Hoffmann-La Roche Ltd.
Novartis AG
Pfizer Inc.
Tarveda Therapeutics Inc.
Teva Pharmaceutical Industries Ltd.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Somatostatin Analogue Drug Market Size 2017-2028
2.1.2 Somatostatin Analogue Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Somatostatin Analogue Drug Segment by Type
2.2.1 Octreotide
2.2.2 Lanreotide
2.2.3 Pasireotide
2.3 Somatostatin Analogue Drug Market Size by Type
2.3.1 Somatostatin Analogue Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Somatostatin Analogue Drug Market Size Market Share by Type (2017-2022)
2.4 Somatostatin Analogue Drug Segment by Application
2.4.1 Acromegaly
2.4.2 Neuroendocrine Tumor (NET)
2.4.3 Others
2.5 Somatostatin Analogue Drug Market Size by Application
2.5.1 Somatostatin Analogue Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Somatostatin Analogue Drug Market Size Market Share by Application (2017-2022)
3 Somatostatin Analogue Drug Market Size by Player
3.1 Somatostatin Analogue Drug Market Size Market Share by Players
3.1.1 Global Somatostatin Analogue Drug Revenue by Players (2020-2022)
3.1.2 Global Somatostatin Analogue Drug Revenue Market Share by Players (2020-2022)
3.2 Global Somatostatin Analogue Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Somatostatin Analogue Drug by Regions
4.1 Somatostatin Analogue Drug Market Size by Regions (2017-2022)
4.2 Americas Somatostatin Analogue Drug Market Size Growth (2017-2022)
4.3 APAC Somatostatin Analogue Drug Market Size Growth (2017-2022)
4.4 Europe Somatostatin Analogue Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Somatostatin Analogue Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Somatostatin Analogue Drug Market Size by Country (2017-2022)
5.2 Americas Somatostatin Analogue Drug Market Size by Type (2017-2022)
5.3 Americas Somatostatin Analogue Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Somatostatin Analogue Drug Market Size by Region (2017-2022)
6.2 APAC Somatostatin Analogue Drug Market Size by Type (2017-2022)
6.3 APAC Somatostatin Analogue Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Somatostatin Analogue Drug by Country (2017-2022)
7.2 Europe Somatostatin Analogue Drug Market Size by Type (2017-2022)
7.3 Europe Somatostatin Analogue Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Somatostatin Analogue Drug by Region (2017-2022)
8.2 Middle East & Africa Somatostatin Analogue Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Somatostatin Analogue Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Somatostatin Analogue Drug Market Forecast
10.1 Global Somatostatin Analogue Drug Forecast by Regions (2023-2028)
10.1.1 Global Somatostatin Analogue Drug Forecast by Regions (2023-2028)
10.1.2 Americas Somatostatin Analogue Drug Forecast
10.1.3 APAC Somatostatin Analogue Drug Forecast
10.1.4 Europe Somatostatin Analogue Drug Forecast
10.1.5 Middle East & Africa Somatostatin Analogue Drug Forecast
10.2 Americas Somatostatin Analogue Drug Forecast by Country (2023-2028)
10.2.1 United States Somatostatin Analogue Drug Market Forecast
10.2.2 Canada Somatostatin Analogue Drug Market Forecast
10.2.3 Mexico Somatostatin Analogue Drug Market Forecast
10.2.4 Brazil Somatostatin Analogue Drug Market Forecast
10.3 APAC Somatostatin Analogue Drug Forecast by Region (2023-2028)
10.3.1 China Somatostatin Analogue Drug Market Forecast
10.3.2 Japan Somatostatin Analogue Drug Market Forecast
10.3.3 Korea Somatostatin Analogue Drug Market Forecast
10.3.4 Southeast Asia Somatostatin Analogue Drug Market Forecast
10.3.5 India Somatostatin Analogue Drug Market Forecast
10.3.6 Australia Somatostatin Analogue Drug Market Forecast
10.4 Europe Somatostatin Analogue Drug Forecast by Country (2023-2028)
10.4.1 Germany Somatostatin Analogue Drug Market Forecast
10.4.2 France Somatostatin Analogue Drug Market Forecast
10.4.3 UK Somatostatin Analogue Drug Market Forecast
10.4.4 Italy Somatostatin Analogue Drug Market Forecast
10.4.5 Russia Somatostatin Analogue Drug Market Forecast
10.5 Middle East & Africa Somatostatin Analogue Drug Forecast by Region (2023-2028)
10.5.1 Egypt Somatostatin Analogue Drug Market Forecast
10.5.2 South Africa Somatostatin Analogue Drug Market Forecast
10.5.3 Israel Somatostatin Analogue Drug Market Forecast
10.5.4 Turkey Somatostatin Analogue Drug Market Forecast
10.5.5 GCC Countries Somatostatin Analogue Drug Market Forecast
10.6 Global Somatostatin Analogue Drug Forecast by Type (2023-2028)
10.7 Global Somatostatin Analogue Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Camurus AB
11.1.1 Camurus AB Company Information
11.1.2 Camurus AB Somatostatin Analogue Drug Product Offered
11.1.3 Camurus AB Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Camurus AB Main Business Overview
11.1.5 Camurus AB Latest Developments
11.2 Chiasma
11.2.1 Chiasma Company Information
11.2.2 Chiasma Somatostatin Analogue Drug Product Offered
11.2.3 Chiasma Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Chiasma Main Business Overview
11.2.5 Chiasma Latest Developments
11.3 Ipsen Group
11.3.1 Ipsen Group Company Information
11.3.2 Ipsen Group Somatostatin Analogue Drug Product Offered
11.3.3 Ipsen Group Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Ipsen Group Main Business Overview
11.3.5 Ipsen Group Latest Developments
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH Company Information
11.4.2 Boehringer Ingelheim International GmbH Somatostatin Analogue Drug Product Offered
11.4.3 Boehringer Ingelheim International GmbH Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Boehringer Ingelheim International GmbH Main Business Overview
11.4.5 Boehringer Ingelheim International GmbH Latest Developments
11.5 Eli Lilly & Co.
11.5.1 Eli Lilly & Co. Company Information
11.5.2 Eli Lilly & Co. Somatostatin Analogue Drug Product Offered
11.5.3 Eli Lilly & Co. Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Eli Lilly & Co. Main Business Overview
11.5.5 Eli Lilly & Co. Latest Developments
11.6 F. Hoffmann-La Roche Ltd.
11.6.1 F. Hoffmann-La Roche Ltd. Company Information
11.6.2 F. Hoffmann-La Roche Ltd. Somatostatin Analogue Drug Product Offered
11.6.3 F. Hoffmann-La Roche Ltd. Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.6.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.7 Novartis AG
11.7.1 Novartis AG Company Information
11.7.2 Novartis AG Somatostatin Analogue Drug Product Offered
11.7.3 Novartis AG Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novartis AG Main Business Overview
11.7.5 Novartis AG Latest Developments
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Information
11.8.2 Pfizer Inc. Somatostatin Analogue Drug Product Offered
11.8.3 Pfizer Inc. Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Pfizer Inc. Main Business Overview
11.8.5 Pfizer Inc. Latest Developments
11.9 Tarveda Therapeutics Inc.
11.9.1 Tarveda Therapeutics Inc. Company Information
11.9.2 Tarveda Therapeutics Inc. Somatostatin Analogue Drug Product Offered
11.9.3 Tarveda Therapeutics Inc. Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Tarveda Therapeutics Inc. Main Business Overview
11.9.5 Tarveda Therapeutics Inc. Latest Developments
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Information
11.10.2 Teva Pharmaceutical Industries Ltd. Somatostatin Analogue Drug Product Offered
11.10.3 Teva Pharmaceutical Industries Ltd. Somatostatin Analogue Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.10.5 Teva Pharmaceutical Industries Ltd. Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Somatostatin Analogue Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Octreotide
Table 3. Major Players of Lanreotide
Table 4. Major Players of Pasireotide
Table 5. Somatostatin Analogue Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Somatostatin Analogue Drug Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Somatostatin Analogue Drug Market Size Market Share by Type (2017-2022)
Table 8. Somatostatin Analogue Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Somatostatin Analogue Drug Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Somatostatin Analogue Drug Market Size Market Share by Application (2017-2022)
Table 11. Global Somatostatin Analogue Drug Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Somatostatin Analogue Drug Revenue Market Share by Player (2020-2022)
Table 13. Somatostatin Analogue Drug Key Players Head office and Products Offered
Table 14. Somatostatin Analogue Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Somatostatin Analogue Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Somatostatin Analogue Drug Market Size Market Share by Regions (2017-2022)
Table 19. Americas Somatostatin Analogue Drug Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Somatostatin Analogue Drug Market Size Market Share by Country (2017-2022)
Table 21. Americas Somatostatin Analogue Drug Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Somatostatin Analogue Drug Market Size Market Share by Type (2017-2022)
Table 23. Americas Somatostatin Analogue Drug Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Somatostatin Analogue Drug Market Size Market Share by Application (2017-2022)
Table 25. APAC Somatostatin Analogue Drug Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Somatostatin Analogue Drug Market Size Market Share by Region (2017-2022)
Table 27. APAC Somatostatin Analogue Drug Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Somatostatin Analogue Drug Market Size Market Share by Type (2017-2022)
Table 29. APAC Somatostatin Analogue Drug Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Somatostatin Analogue Drug Market Size Market Share by Application (2017-2022)
Table 31. Europe Somatostatin Analogue Drug Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Somatostatin Analogue Drug Market Size Market Share by Country (2017-2022)
Table 33. Europe Somatostatin Analogue Drug Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Somatostatin Analogue Drug Market Size Market Share by Type (2017-2022)
Table 35. Europe Somatostatin Analogue Drug Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Somatostatin Analogue Drug Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Somatostatin Analogue Drug Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Somatostatin Analogue Drug Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Somatostatin Analogue Drug Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Somatostatin Analogue Drug Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Somatostatin Analogue Drug Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Somatostatin Analogue Drug Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Somatostatin Analogue Drug
Table 44. Key Market Challenges & Risks of Somatostatin Analogue Drug
Table 45. Key Industry Trends of Somatostatin Analogue Drug
Table 46. Global Somatostatin Analogue Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Somatostatin Analogue Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Somatostatin Analogue Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Somatostatin Analogue Drug Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Somatostatin Analogue Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Somatostatin Analogue Drug Market Size Market Share Forecast by Application (2023-2028)
Table 52. Camurus AB Details, Company Type, Somatostatin Analogue Drug Area Served and Its Competitors
Table 53. Camurus AB Somatostatin Analogue Drug Product Offered
Table 54. Camurus AB Somatostatin Analogue Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Camurus AB Main Business
Table 56. Camurus AB Latest Developments
Table 57. Chiasma Details, Company Type, Somatostatin Analogue Drug Area Served and Its Competitors
Table 58. Chiasma Somatostatin Analogue Drug Product Offered
Table 59. Chiasma Main Business
Table 60. Chiasma Somatostatin Analogue Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Chiasma Latest Developments
Table 62. Ipsen Group Details, Company Type, Somatostatin Analogue Drug Area Served and Its Competitors
Table 63. Ipsen Group Somatostatin Analogue Drug Product Offered
Table 64. Ipsen Group Main Business
Table 65. Ipsen Group Somatostatin Analogue Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Ipsen Group Latest Developments
Table 67. Boehringer Ingelheim International GmbH Details, Company Type, Somatostatin Analogue Drug Area Served and Its Competitors
Table 68. Boehringer Ingelheim International GmbH Somatostatin Analogue Drug Product Offered
Table 69. Boehringer Ingelheim International GmbH Main Business
Table 70. Boehringer Ingelheim International GmbH Somatostatin Analogue Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Boehringer Ingelheim International GmbH Latest Developments
Table 72. Eli Lilly & Co. Details, Company Type, Somatostatin Analogue Drug Area Served and Its Competitors
Table 73. Eli Lilly & Co. Somatostatin Analogue Drug Product Offered
Table 74. Eli Lilly & Co. Main Business
Table 75. Eli Lilly & Co. Somatostatin Analogue Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Eli Lilly & Co. Latest Developments
Table 77. F. Hoffmann-La Roche Ltd. Details, Company Type, Somatostatin Analogue Drug Area Served and Its Competitors
Table 78. F. Hoffmann-La Roche Ltd. Somatostatin Analogue Drug Product Offered
Table 79. F. Hoffmann-La Roche Ltd. Main Business
Table 80. F. Hoffmann-La Roche Ltd. Somatostatin Analogue Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. F. Hoffmann-La Roche Ltd. Latest Developments
Table 82. Novartis AG Details, Company Type, Somatostatin Analogue Drug Area Served and Its Competitors
Table 83. Novartis AG Somatostatin Analogue Drug Product Offered
Table 84. Novartis AG Main Business
Table 85. Novartis AG Somatostatin Analogue Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Novartis AG Latest Developments
Table 87. Pfizer Inc. Details, Company Type, Somatostatin Analogue Drug Area Served and Its Competitors
Table 88. Pfizer Inc. Somatostatin Analogue Drug Product Offered
Table 89. Pfizer Inc. Main Business
Table 90. Pfizer Inc. Somatostatin Analogue Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Pfizer Inc. Latest Developments
Table 92. Tarveda Therapeutics Inc. Details, Company Type, Somatostatin Analogue Drug Area Served and Its Competitors
Table 93. Tarveda Therapeutics Inc. Somatostatin Analogue Drug Product Offered
Table 94. Tarveda Therapeutics Inc. Main Business
Table 95. Tarveda Therapeutics Inc. Somatostatin Analogue Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Tarveda Therapeutics Inc. Latest Developments
Table 97. Teva Pharmaceutical Industries Ltd. Details, Company Type, Somatostatin Analogue Drug Area Served and Its Competitors
Table 98. Teva Pharmaceutical Industries Ltd. Somatostatin Analogue Drug Product Offered
Table 99. Teva Pharmaceutical Industries Ltd. Main Business
Table 100. Teva Pharmaceutical Industries Ltd. Somatostatin Analogue Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Teva Pharmaceutical Industries Ltd. Latest Developments
List of Figures
Figure 1. Somatostatin Analogue Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Somatostatin Analogue Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Somatostatin Analogue Drug Market Size Market Share by Type in 2021
Figure 7. Somatostatin Analogue Drug in Acromegaly
Figure 8. Global Somatostatin Analogue Drug Market: Acromegaly (2017-2022) & ($ Millions)
Figure 9. Somatostatin Analogue Drug in Neuroendocrine Tumor (NET)
Figure 10. Global Somatostatin Analogue Drug Market: Neuroendocrine Tumor (NET) (2017-2022) & ($ Millions)
Figure 11. Somatostatin Analogue Drug in Others
Figure 12. Global Somatostatin Analogue Drug Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Somatostatin Analogue Drug Market Size Market Share by Application in 2021
Figure 14. Global Somatostatin Analogue Drug Revenue Market Share by Player in 2021
Figure 15. Global Somatostatin Analogue Drug Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Somatostatin Analogue Drug Market Size 2017-2022 ($ Millions)
Figure 17. APAC Somatostatin Analogue Drug Market Size 2017-2022 ($ Millions)
Figure 18. Europe Somatostatin Analogue Drug Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Somatostatin Analogue Drug Market Size 2017-2022 ($ Millions)
Figure 20. Americas Somatostatin Analogue Drug Value Market Share by Country in 2021
Figure 21. Americas Somatostatin Analogue Drug Consumption Market Share by Type in 2021
Figure 22. Americas Somatostatin Analogue Drug Market Size Market Share by Application in 2021
Figure 23. United States Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Somatostatin Analogue Drug Market Size Market Share by Region in 2021
Figure 28. APAC Somatostatin Analogue Drug Market Size Market Share by Application in 2021
Figure 29. China Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Somatostatin Analogue Drug Market Size Market Share by Country in 2021
Figure 36. Europe Somatostatin Analogue Drug Market Size Market Share by Type in 2021
Figure 37. Europe Somatostatin Analogue Drug Market Size Market Share by Application in 2021
Figure 38. Germany Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Somatostatin Analogue Drug Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Somatostatin Analogue Drug Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Somatostatin Analogue Drug Market Size Market Share by Application in 2021
Figure 46. Egypt Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Somatostatin Analogue Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 52. APAC Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 53. Europe Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 55. United States Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 56. Canada Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 59. China Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 60. Japan Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 61. Korea Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 63. India Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 64. Australia Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 65. Germany Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 66. France Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 67. UK Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 68. Italy Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 69. Russia Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 70. Spain Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 73. Israel Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Somatostatin Analogue Drug Market Size 2023-2028 ($ Millions)
